Activision Faces Backlash Over AI-Generated Call of Duty Items and Layoffs Linked to AI Decisions
Activision reportedly assured artists that AI would be used only for internal concept work, not final game assets. Devamını Oku
Yazılar
GE HealthCare Partners with Amazon Web Services to Develop Generative AI for Medical Data Analysis
GE HealthCare announced a strategic collaboration with Amazon Web Services (AWS) to develop generative artificial intelligence (AI) models and tools aimed at enhancing the analysis of complex medical data. This partnership targets the healthcare industry, which generates nearly a third of the world’s data, much of which remains underutilized due to its fragmented and inaccessible nature.
With 97% of hospital data going unused, according to a Deloitte report, GE HealthCare sees an opportunity to leverage generative AI to optimize data use across healthcare operations. The collaboration with AWS will focus on creating AI models that can streamline various medical processes, including screenings, diagnoses, decision support, and workflow management such as scheduling.
Dr. Taha Kass-Hout, GE HealthCare’s global chief science and technology officer, highlighted that this partnership will enable hospitals and clinicians to maximize the potential of their existing data. AWS’s advanced solutions, including Amazon Bedrock and Amazon SageMaker, will provide the technical infrastructure necessary for developing these AI models at scale.
Additionally, GE HealthCare plans to utilize AWS’s AI tools to boost internal productivity. One of the initial projects includes deploying Amazon Q Developer, an assistive tool that generates real-time code suggestions for software developers, thereby improving their efficiency.
While GE HealthCare already offers AI tools, this collaboration with AWS is expected to accelerate the development and deployment of new AI-driven medical applications. These innovations will initially be available to GE HealthCare employees and customers, with plans for broader accessibility in the future. The company maintains strict testing standards to ensure the reliability and safety of its AI applications.
Elon Musk Revives Lawsuit Against Sam Altman and OpenAI
Elon Musk has reignited a lawsuit against ChatGPT creator OpenAI and its CEO Sam Altman, alleging the company prioritized profits over the public good. Musk, who co-founded OpenAI in 2015, claims Altman shifted the company’s focus towards commercial gain once its generative AI technology began to flourish. The lawsuit seeks to void OpenAI’s licensing agreement with Microsoft, contending that the use of OpenAI’s language models exceeds the scope of their partnership. Microsoft has invested billions into OpenAI in exchange for utilizing its AI models.
In June, Musk withdrew a prior lawsuit accusing OpenAI and Altman of abandoning their original mission to develop AI for humanity’s benefit. Filed in February, that suit was dismissed without explanation. Musk asserts that OpenAI’s founders initially committed to creating AI that would serve humanity rather than commercial interests. OpenAI and Musk did not respond to Reuters’ requests for comment.